Search research articles
Contact Us
Filters
Showing results (231-240 of 254) with videos related to
Page
of 26
Sort By:
Annals of Hematology
|
July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
Jingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
Ebiomedicine
|
October 22, 2024
SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer
Haoran Feng, Junxian Yu, Zhuoqing Xu, et al.
Cancer Biology & Medicine
|
March 23, 2021
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
Wei Zhang, Liping Su, Lihong Liu, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial
Huangming Hong, Zegeng Chen, Jie Cui, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 25, 2025
Loss of DRD5P2 in hypoxia attenuates Rock2 degradation to promote EMT and gastric cancer metastasis
Zhenjia Yu, Tao Pan, Xiaofeng Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
June 2, 2018
Home-Based Transcutaneous Neuromodulation Improved Constipation via Modulating Gastrointestinal Hormones and Bile Acids
Zhenyang Ge, Zhijun Duan, Hang Yang, et al.
Cell Stem Cell
|
December 7, 2014
Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells
Lei Ye, Ying-Hua Chang, Qiang Xiong, et al.
Theranostics
|
June 16, 2025
BCAA catabolism targeted therapy for heart failure with preserved ejection fraction
Meng Wang, Zhao Liu, Shuxun Ren, et al.
Signal Transduction and Targeted Therapy
|
April 16, 2024
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
Huaqing Wang, Jifeng Feng, Yanyan Liu, et al.
Blood Cancer Journal
|
March 18, 2026
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)
Juying Wei, Qingqing Cai, Liling Zhang, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 254) with videos related to
Sort By:
Page
of 26
Annals of Hematology
|
July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
Jingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.
Ebiomedicine
|
October 22, 2024
SLC7A9 suppression increases chemosensitivity by inducing ferroptosis via the inhibition of cystine transport in gastric cancer
Haoran Feng, Junxian Yu, Zhuoqing Xu, et al.
Cancer Biology & Medicine
|
March 23, 2021
The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study
Wei Zhang, Liping Su, Lihong Liu, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial
Huangming Hong, Zegeng Chen, Jie Cui, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
April 25, 2025
Loss of DRD5P2 in hypoxia attenuates Rock2 degradation to promote EMT and gastric cancer metastasis
Zhenjia Yu, Tao Pan, Xiaofeng Wang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
June 2, 2018
Home-Based Transcutaneous Neuromodulation Improved Constipation via Modulating Gastrointestinal Hormones and Bile Acids
Zhenyang Ge, Zhijun Duan, Hang Yang, et al.
Cell Stem Cell
|
December 7, 2014
Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells
Lei Ye, Ying-Hua Chang, Qiang Xiong, et al.
Theranostics
|
June 16, 2025
BCAA catabolism targeted therapy for heart failure with preserved ejection fraction
Meng Wang, Zhao Liu, Shuxun Ren, et al.
Signal Transduction and Targeted Therapy
|
April 16, 2024
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma
Huaqing Wang, Jifeng Feng, Yanyan Liu, et al.
Blood Cancer Journal
|
March 18, 2026
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)
Juying Wei, Qingqing Cai, Liling Zhang, et al.
Page
of 26